GeneNews Limited (TSX:GEN) has initiated an orderly restructuring of its operations, which may include a strategic financing, sale, merger or other business combination.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -.--% |
|
-.--% | -11.11% |
May. 21 | Transcript : StageZero Life Sciences Ltd., Q1 2024 Earnings Call, May 21, 2024 | |
May. 16 | StageZero Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 3.62M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- SZLS Stock
- News StageZero Life Sciences Ltd.
- GeneNews Mulls Financing